Abstract Genetic variation in immune-related genes, such as IL10 and TNF, have been associated with the development of non-Hodgkin lymphoma (NHL) in Caucasian populations. To test the hypothesis that IL10 and TNF polymorphisms may be associated with NHL risk in Asian populations, we genotyped 20 single nucleotide polymorphisms (SNPs) within the IL10 and TNF/LTA loci in three independent case-control studies (2635 cases and 4234 controls). IL10 rs1800871, rs1800872, and rs1800896 were genotyped in all three studies, while 5 of the remaining SNPs were genotyped in two studies, and 12 in a single study. IL10 rs1800896 was associated with B cell lymphoma [per-allele odds ratio (OR) = 1.25, 95 % confidence interval (CI) 1.08-1.45; p trend = 0.003], specifically diffuse large B cell lymphoma (DLBCL) (per-allele OR = 1.29, 95 % CI 1.08-1.53; p trend = 0.004), as well as T cell lymphoma (per-allele OR = 1.44, 95 % CI 1.13-1.82; p trend = 0.003). TNF rs1800629, which was genotyped in only two of our studies, was also associated with B cell lymphoma (per-allele OR = 0.77, 95 % CI 0.64-0.91; p trend = 0.003), specifically DLBCL (per-allele OR = 0.69, 95 % CI 0.55-0.86; p trend = 0.001). Our findings suggest that genetic variation in IL10 and TNF may also play a role in lymphomagenesis in Asian populations.
Introduction
Non-Hodgkin lymphoma (NHL) is the 8th leading incident cancer among men worldwide and the 10th among women [6] . There are few known risk factors for NHL beyond family history of NHL [15] and altered immune-function [11] . As such, many candidate-gene association studies of NHL have focused on cytokines, which are secreted proteins that play a critical role in regulating the immune system [4] .
Interleukin 10 (IL10) and tumor necrosis factor (TNF) are cytokines that have been the subject of extensive epidemiological investigations into whether genetic variation in these genes is associated with NHL risk [12, 13] . These analyses, however, have included primarily only Caucasians. Rothman et al. [12] initially reported associations between IL10 and TNF single nucleotide polymorphisms (SNPs) in *3600 cases of NHL and *4000 controls from North American and European studies participating in the InterLymph Consortium. Skibola et al. [13] extended these findings by pooling additional InterLymph-participating studies for a total of *8000 cases and *8500 controls. While Skibola et al. was able to perform analyses by ethnicity, including Asians, these analyses were considered exploratory due to limited sample size.
Given the previous findings in Caucasians, and the lack of sufficient data exploring these relationships in Asian populations to date, we investigated the possible associations of genetic variants in IL10 and TNF with NHL risk by pooling data from three independent Asian case-control studies (2635 cases; 4234 controls) that genotyped SNPs in these two gene regions.
Methods
Our study population comprised three independent casecontrol studies carried out in Hong Kong, South Korea, and mainland China (Jinan, China). Subjects in the case-control study in Hong Kong were recruited from patients of the Queen Mary and Queen Elizabeth Hospitals in Hong Kong, using similar methods as a previous study of chronic lymphocytic leukemia [7] . Cases were patients with NHL diagnosed according to the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues. Patients with non-cancer diagnoses in the Queen Mary Hospital were used as controls. In Jinan, patients were recruited from the Shandong Cancer Hospital and Institute and the Shandong University Qilu Hospital. The case group comprised patients newly diagnosed with NHL according to the World Health Organization criteria. Controls were selected from the patient population without evidence of any personal or family history of cancer or other serious illness. In the case-control study carried out in South Korea, cases and controls were recruited from the Chonnam National University Hwasun Hospital in Jeollanam-do, South Korea. All three studies included only newly diagnosed NHL cases. To ensure the protection of human subjects, the protocol for each study was approved by the local Institutional Review Board.
In total, 20 SNPs in the IL10 and TNF/LTA gene regions were genotyped (Supplemental Table 1 ). SNPs were genotyped in blood samples by TaqMan as described at http:// snp500cancer.nci.nih.gov/. Samples from Hong Kong were genotyped at the National Cancer Institute Core Genotyping Facility (CGF) in Gaithersburg, MD. Samples from South Korea and Jinan were genotyped at their local institutions. Hardy-Weinberg equilibrium (HWE) for each SNP was tested in controls using Fisher's exact test. None of the SNPs deviated substantially from HWE (p \ 0.0001) (Supplemental Table 1 ).
Associations of each SNP with NHL risk were estimated by odds ratios (OR) and 95 % confidence intervals (CI) calculated using unconditional logistic regression adjusted for age (reference group, \40 years old), gender (reference group, male), and study center (reference group, Hong Kong). The homozygote of the common allele was used as the reference group. Gene-dose effects were estimated by a linear trend test based on the number of variant alleles present (0, 1, 2). Polytomous regression models were used to evaluate SNP effects among B cell lymphoma subtypes [diffuse large B cell lymphoma (DLBCL), follicular lymphoma (FL), mucosa-associated lymphoid tissue (MALT), mantle cell lymphoma (MCL), chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)] and T cell lymphoma subtypes [natural killer lymphoma (NK), peripheral T cell lymphoma (PTCL)]. For IL10 rs1800896 and TNF rs1800629, differences between DLBCL and FL were determined by case-case analyses comparing the gene-dose effects.
Results
Our pooled population of subjects from Hong Kong (1174 cases, 2034 controls), South Korea (949 cases, 1700 controls), and Jinan (512 cases, 500 controls) was composed of 2635 NHL cases and 4234 controls (Table 1 ). Cases and controls were similar in age in our pooled population.
In total, 20 SNPs were genotyped in IL10 and TNF/LTA (Supplemental Table 1 ). The NHL risk associated with all SNPs, as well as the allele distributions, is provided in Supplemental Table 2 . The associations of each SNP with B cell lymphoma subtypes are provided in Supplemental Table 3 . The associations of each SNP with T cell lymphoma subtypes are provided in Supplemental Table 4 . Of the 13 SNPs genotyped in IL10, three (rs1800871, rs1800872, and rs1800896) were genotyped in all three of the studies included in our analysis. IL10 rs1800896 was associated with increased risk of NHL (OR per-allele = 1.28, 95 % CI 1.12-1.46; p trend = 0.0003), as well as B cell (OR per-allele = 1.25, 95 % CI 1.08-1.45; p trend = 0.003) and T cell (OR per-allele = 1.44, 95 % CI 1.13-1.82; p trend = 0.003) lymphomas (Table 2; Supplemental  Table 2 ). These associations were consistent across the studies. When exploring NHL subtypes further, the association between IL10 rs1800896 and B cell lymphoma was restricted to DLBCL (OR per-allele = 1.29, 95 % CI 1.08-1.53; p trend = 0.004) (Table 2; Supplemental Table 3 ). The association between IL10 rs1800896 and T cell lymphoma was restricted to NK T cell lymphoma (OR per-allele = 1.52, 95 % CI 1.04-2.23; p trend = 0.030) ( Table 2 ; Supplemental Table 4 ). Heterogeneity was observed when comparing the per-allele risks associated with IL10 rs1800896 and DLBCL and FL (p heterogeneity = 0.01).
Of the 7 SNPs genotyped in TNF/LTA, four (rs1800629, rs1799724, rs1800630, rs909253) were genotyped in two studies (Hong Kong, South Korea). Both TNF rs1800629 and (Table 3; Supplemental Table 2 ). TNF rs1800629 was associated with DLBCL (p trend = 0.001) ( Table 3; Supplemental Table 3 ). No heterogeneity was observed when comparing the per-allele risks associated with TNF rs1800629 and DLBCL and FL (p heterogeneity = 0.67).
Discussion
We have extended the previous observations that NHL risk is associated with IL10 and TNF variants in Caucasians by evaluating these associations in three independent populations from Hong Kong, South Korea, and mainland China. Our study suggests that genetic variation in IL10 and TNF may play a role in lymphomagenesis in these previously under-studied populations. We found IL10 rs1800896 to be associated with B cell lymphoma, specifically DLBCL, as well as T cell lymphoma. Similar to our findings, previous studies in Caucasians observed an association between the G allele at IL10 rs1800896 and increased risk of DLBCL but not FL [12, 13] . Of note, however, the risks observed by Rothman et al. [12] were not significantly different by histological type (DLBCL vs. FL). Exploratory analyses with limited power and in a relatively small number of Asians (\300 cases; \300 controls) found the association between IL10 rs1800896 and DLBCL to be suggestive, but not statistically significant [13] . By conducting our analyses with an order of magnitude larger sample size, we have been able to confirm this observation, finding that the G allele at IL10 rs1800896 infers about a 25 % increased risk of DLBCL in Asian populations.
The A allele at TNF rs1800629 was associated with a decreased risk of DLBCL in our study populations. This is inconsistent with Rothman et al.'s [12] and Skibola et al.'s [13] findings among Caucasians. However, similar to our findings, Asian-specific analyses carried out by Skibola et al. found the A allele at TNF rs1800629 to be associated with a decreased risk of B cell lymphoma (OR AG/AA vs GG = 0.50, 95 % CI 0.30-0.85; p trend = 0.016) and DLBCL (OR AG/AA vs GG = 0.60, 95 % CI 0.30-1.18; p trend = 0.24) [13] . The allelic distributions in both the current study and Skibola et al.'s are consistent with Asian HapMap populations (JPT: G allele = 0.977, A allele = 0.023; HCB: G Odds ratios (OR) and 95 % confidence intervals (CI) adjusted for age, gender, and study center. B cell lymphoma subtypes: diffuse large B cell lymphoma (DLBCL), follicular lymphoma (FL), T cell lymphoma subtypes: natural killer lymphoma (NK) [10, 14] . Our pooled analysis of studies carried out in Asia provides evidence that variation in IL10 and TNF influence lymphoma susceptibility beyond Caucasian populations. These findings have translational relevance as adverse prognosis of NHL has been observed in patients with altered IL10 [1] and TNF [16] concentrations, and genetic variation leading to altered IL-10 expression has been associated with the development of lymphoma in both the general population [3] and AIDS patients [2] . The main strength of our analysis is the large sample size, pooled from three independent case-control studies. While previous analyses have had larger samples sizes, this report is the largest to date in non-Caucasian populations. The strong a priori hypotheses of these SNPs and the fact that our strongest association remains significant after applying a Bonferroni correction lend strength to our findings. One possible limitation of our study is potential population stratification. However, it is unlikely that this would explain our results given that we adjusted for study center and that the populations within each center are relatively homogenous. Finally, given the exposure levels in Asia to suspected or known lymphomagens with immunotoxic properties, such as trichloroethylene [5] and benzene [9] , and that interactions between loci involved in immunologic regulation and these chemicals may exist [9] , high-quality genetic association studies that integrate cutting edge environmental and occupational exposure assessments are warranted. It is also the case that our results should be viewed as exploratory until confirmed in larger studies in Asia, especially given some of the low allelic frequencies we observed in these populations. 
